Jenny Lam

Associate Professor

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Drug Delivery Drug Delivery professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jenny Lam is an Associate Professor at University College London, UK. Her research areas include pulmonary delivery systems, asthma management, and novel drug formulations for cancer and infectious diseases. Recent publications highlight her work on peptide/RNA complexes, antimicrobial therapies, and the development of monitoring tools for childhood asthma.

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Andrea Duranti

Associate professor

University of Urbino Carlo Bo

ITALY

View details

Gilbert Otto Fruhwirth

Reader

King’s College London

UNITED KINGDOM

View details

James Mason

King’s College London

UNITED KINGDOM

View details

Philip Chi Lip Kwok

University of Sydney

AUSTRALIA

View details

Jamie Chien-Ming Hsieh

Lecturer

University of Kent

UNITED KINGDOM

View details

Simone Lucarini

Associate Professor of Medicinal Chemistry

Università degli Studi di Udine

ITALY

View details

Diego Romano PERINELLI

University of Camerino

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jenny Lam

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Robust peptide/RNA complexes prepared with microfluidic mixing for pulmonary delivery by nebulisation

Evaluation of bronchial hyperresponsiveness in asthmatic paediatric patients using mannitol challenge test - Impacts of body mass index.

Co-delivery of PD-L1- and EGFR-targeting siRNAs by synthetic PEG12-KL4 peptide to the lungs as potential strategy against non-small cell lung cancer

Phage-derived polysaccharide depolymerase potentiates ceftazidime efficacy against Acinetobacter baumannii pneumonia via low-serum-dependent mechanisms.

Objective monitoring tools for improved management of childhood asthma.

Oral Delivery of Photopolymerizable Nanogels Loaded with Gemcitabine for Pancreatic Cancer Therapy: Formulation Design, and in vitro and in vivo Evaluations.

Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis.

Storage stability of lysostaphin solution and its pulmonary delivery.

Synthesis and Properties of Sucrose- and Lactose-Based Aromatic Ester Surfactants as Potential Drugs Permeability Enhancers

Inhalable neutralizing antibodies – promising approach to combating respiratory viral infections

Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation.

Bolaamphiphile Analogues of 12-bis-THA Cl <sub>2</sub> Are Potent Antimicrobial Therapeutics with Distinct Mechanisms of Action against Bacterial, Mycobacterial, and Fungal Pathogens

Aberrant Transferrin and Ferritin Upregulation Elicits Iron Accumulation and Oxidative Inflammaging Causing Ferroptosis and Undermines Estradiol Biosynthesis in Aging Rat Ovaries by Upregulating NF-Κb-Activated Inducible Nitric Oxide Synthase: First Demonstration of an Intricate Mechanism

Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4Rα Antibody for Pulmonary Delivery

Mediating bio-fate of polymeric cholecalciferol nanoparticles through rational size control.

Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration.

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy

Optimization of PEGylated KL4 Peptide for siRNA Delivery with Improved Pulmonary Tolerance

Inhalable Protein Powder Prepared by Spray-Freeze-Drying Using Hydroxypropyl-β-Cyclodextrin as Excipient

Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses

Collaborators (7)

Andrea Duranti

Gilbert Otto Fruhwirth

James Mason

Philip Chi Lip Kwok

Jamie Chien-Ming Hsieh

Simone Lucarini

Diego Romano PERINELLI

Make your next move.